* Teladoc Health Inc TDOC.N reported a quarterly adjusted
loss
of 28 cents per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of -40 cents. The mean expectation of twenty seven analysts for
the quarter was for a loss of 35 cents per share. Wall Street
expected results to range from -41 cents to -18 cents per share.
* Revenue fell 1.5% to $642.44 million from a year ago;
analysts
expected $649.65 million.
* Teladoc Health Inc's reported EPS for the quarter was a
loss of
$4.92.
* The company reported a quarterly loss of $837.67 million.
* Teladoc Health Inc shares had fallen by 0.5% this
quarter and
lost 54.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 2.5%
in the last three months.
* In the last 30 days, four analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 23
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is also "hold"
Wall Street's median 12-month price target for Teladoc Health
Inc is $15.00
This summary was machine generated from LSEG data July 31 at
10:28 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.35 -0.28 Beat
Mar. 31 2024 -0.46 -0.49 Missed
Dec. 31 2023 -0.21 -0.17 Beat
Sep. 30 2023 -0.37 -0.35 Beat